In vitro efficacy of antifungal treatment using riboflavin/UV-A (365 nm) combination and amphotericin B

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 8, 2010, Pages 3950-3953

  Sauer, Arnaud ^a,b   Letscher Bru, Valérie ^b   Speeg Schatz, Claude ^a   Touboul, David ^c   Colin, Joseph ^c   Candolfi, Ermanno ^b   Bourcier, Tristan ^a  

^a HÔPITAL CIVIL   (France)

^b UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^c BORDEAUX UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; RIBOFLAVIN; RICROLIN; UNCLASSIFIED DRUG; ANTIFUNGAL AGENT;

ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; CONTROLLED STUDY; DRUG EFFICACY; FUSARIUM; GROWTH INHIBITION; HUMAN; IN VITRO STUDY; KERATOMYCOSIS; NONHUMAN; PRIORITY JOURNAL; RADIATION EXPOSURE; ULTRAVIOLET A RADIATION; BACTERIAL COUNT; CORNEA ULCER; DRUG EFFECT; FUNGUS; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MULTIMODALITY CANCER THERAPY; PHOTOTHERAPY;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; COLONY COUNT, MICROBIAL; COMBINED MODALITY THERAPY; CORNEAL ULCER; FUNGI; FUSARIUM; HUMANS; MICROBIAL SENSITIVITY TESTS; RIBOFLAVIN; ULTRAVIOLET THERAPY;

EID: 77955905559     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-4013     Document Type: Article

References (24)

1. Thomas PA, Geraldine P. Infectious keratitis. Curr Opin Infect Dis. 2007;20:129-141.
2. Srinivasan M. Fungal keratitis. Curr Opin Ophthalmol. 2004;15: 321-327.
3. Jones A, Muhtaseb M. Use of voriconazole in fungal keratitis. J Cataract Refract Surg. 2008;34:183-184.
4. Thomas PA. Current perspectives on ophthalmic mycoses. Clin Microbiol Rev. 2003;16:730-797.
5. Shukla PK, Kumar M, Keshava GB. Mycotic keratitis: an overview of diagnosis and therapy. Mycoses. 2008;51:183-199.
6. Ruane PH, Edrich R, Gampp D, Keil SD, Leonard RL, Goodrich RP. Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light. Transfusion. 2004; 44:877-885.
7. Tsugita A, Okada Y, Uehara K. Photosensitized inactivation of ribonucleic acids in the presence of riboflavin. Biochim Biophys Acta. 1965;103:360-363.
8. Norval M. The effect of ultraviolet radiation on human viral infections. Photochem Photobiol. 2006;82:1495-1504.
9. Tang HM, Hamblin MR, Yow CM. A comparative in vitro photoinactivation study of clinical isolates of multidrug-resistant pathogens. J Infect Chemother. 2007;13:87-91.
10. Martins SA, Combs JC, Noguera G, et al. Antimicrobial efficacy of riboflavin/UV-A combination (365 nm) in vitro for bacterial and fungal isolates: a potential new treatment for infectious keratitis. Invest Ophthalmol Vis Sci. 2008;49:3402-3408.
11. Sponsel W, Chen N, Dang D, et al. Topical voriconazole as a novel treatment for fungal keratitis. Antimicrob Agents Chemother. 2006;50:262-268.
12. Wollensak G, Spoerl E, Seiler T. Stress-strain measurements of human and porcine corneas after riboflavin-ultraviolet-A-induced cross-linking. J Cataract Refract Surg. 2003;29:1780-1785.
13. Wollensak G, Spoerl E, Reber F, Seiler T. Keratocyte cytotoxicity of riboflavin/UV-A-treatment in vitro. Eye. 2004;18:718-722.
14. Goodrich RP. The use of riboflavin for the inactivation of pathogens in blood products. Vox Sang. 2000;78(suppl 2):211-215.
15. Baier J, Maisch T, Maier M, Engel E, Landthaler M, Baumler W. Singlet oxygen generation by UV-A light exposure of endogenousphotosensitizers. Biophys J. 2006;91:1452-1459.
16. Hiraku Y, Ito K, Hirakawa K, Kawanishi S. Photosensitized DNA damage and its protection via a novel mechanism. Photochem Photobiol. 2007;83:205-212.
17. Das S, Samant M, Garg P, Vaddavalli PK, Vemuganti GK. Role of confocal microscopy in deep fungal keratitis. Cornea. 2009;28:11-13.
18. Vemuganti GK, Garg P, Gopinathan U, et al. Evaluation of agent and host factors in progression of mycotic keratitis: a histologic and microbiologic study of 167 corneal buttons. Ophthalmology. 2002;109:1538-1546.
19. Wollensak G. Crosslinking treatment of progressive keratoconus: new hope. Curr Opin Ophthalmol. 2006;17:356-360.
20. Baginski M, Czub J, Sternal K. Interaction of amphotericin B and its selected derivatives with membranes: molecular modeling studies. Chem Rec. 2006;6:320-332.
21. Resat H, Baginski M. Ion passage pathways and thermodynamics of the amphotericin B membrane channel. Eur Biophys J. 2002;31: 294-305.
22. Ahearne M, Yang Y, Then KY, Liu KK. Non-destructive mechanical characterisation of UV-A/riboflavin crosslinked collagen hydrogels. Br J Ophthalmol. 2008;92:268-271.
23. Stewart JM, Schultz DS, Lee OT, Trinidad ML. Collagen cross-links reduce corneal permeability. Invest Ophthalmol Vis Sci. 2009;50: 1606-1612.
24. Spoerl E, Mrochen M, Sliney D, Trokel S, Seiler T. Safety of UV-Ariboflavin cross-linking of the cornea. Cornea. 2007;26:385-389.